HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seth, R. Articles by MacIntyre, I. Search for Related Content PubMed PubMed Citation Articles by Seth, R. Articles by MacIntyre, I.

A highly sensitive, specific and rapid two-site enzyme-immunometric assay (EIA) for the measurement of immunoreactive (ir) human calcitonin (hCT) in human plasma was developed using high-affinity monoclonal antibodies. The assay was validated in terms of sensitivity, specificity and reproducibility and its performance compared with that of a radioimmunoassay (RIA) employing a polyclonal antiserum. The sensitivity of the overnight EIA (2 pmol/l) was comparable with the long-incubation (7 days) RIA. The overnight RIA had a sensitivity of 10 pmol/l. The inter- and intra-assay variations of the EIA were less than 12%. Some related and non-related peptides were compared with synthetic hCT for cross-reactivity in the assay and were found to be negative. The mean recovery of added synthetic hCT from plasma of normal volunteers was 96%. Both RIA and EIA have been applied to the measurement of ir-hCT in normal volunteers and in patients with medullary carcinoma of the thyroid. In both groups, the level of ir-hCT measured by EIA was found to be lower than that measured by RIA, presumably due to the ability of the more specific EIA to detect only the 'mature' form of the hormone. EIA offers an attractive alternative to the more cumbersome and lengthy RIA in current usage, with the added advantage of employing a non-isotopic label.

J. Endocr. (1988) 119, 351–357

This article has been cited by other articles:

				G. Karanikas, A. Moameni, C. Poetzi, G. Zettinig, K. Kaserer, C. Bieglmayer, B. Niederle, R. Dudczak, and C. Pirich Frequency and Relevance of Elevated Calcitonin Levels in Patients with Neoplastic and Nonneoplastic Thyroid Disease and in Healthy Subjects J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 515 - 519. [Abstract] [Full Text] [PDF]

				P. Niccoli, N. Wion-Barbot, P. Caron, J.-F. Henry, C. de Micco, J.-P. Saint Andre, J.-C. Bigorgne, E. Modigliani, and B. Conte-Devolx Interest of Routine Measurement of Serum Calcitonin: Study in a Large Series of Thyroidectomized Patients J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 338 - 341. [Abstract] [Full Text] [PDF]